Rafael Palhinha Gomes, Business Development leader for Global Personal Healthcare category and Latin America region at Procter and Gamble, shared on LinkedIn:
“At WIN Symposium 2026, precision oncology felt truly global.
I learned from and connected with people from Australia, India, China, Egypt, Jordan, Romania, Italy, the United States, and beyond.
As Wafik El-Deiry has emphasized, WIN connects expertise across borders – from molecular tumor boards to research, industry, and patient advocacy – so precision oncology can reach more patients.
Thank you, Wafik El – Deiry and Razelle Kurzrock, for the event, the connections, the learning, and for recognizing my poster, GBM Precision Ecosystem.
I’m grateful, too, for the support of Sewanti Limaye, Navid Alipour, Michelle R. Dawson, Gillian Lamoury, Sean E. Lawler, Bradley J. Sander, Giselle L. Saulnier Sholler, Attila A. Seyhan, Karan Sood, Vivek Subbiah, Daniel Sur, Robyn Ward, Chris Schuler, and Darren Rhea.
Your support strengthens my commitment to help change the standard of care in Glioblastoma.
Data is the name of the game – and every properly preserved tumor sample is an opportunity to learn.
We need to connect what we learn from tumor tissue with treatment and outcome data, then use technology to make decisions more precise and reduce avoidable costs across the system.
Support the cause at Make the first month count.”
Other articles about glioblastoma and WIN Symposium 2026 on OncoDaily.